Mondrian Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$55.6M |
| 2 |
Itaú Unibanco
ITUB
|
+$43.4M |
| 3 |
Credicorp
BAP
|
+$32.8M |
| 4 |
Maximus
MMS
|
+$31.5M |
| 5 |
DuPont de Nemours
DD
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$35.4M |
| 2 |
Yum China
YUMC
|
+$29.4M |
| 3 |
TSMC
TSM
|
+$15M |
| 4 |
RB Global
RBA
|
+$14.7M |
| 5 |
CAE Inc. Common Shares
CAE
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.18% |
| 2 | Financials | 16.6% |
| 3 | Healthcare | 15.59% |
| 4 | Communication Services | 14.44% |
| 5 | Industrials | 8.35% |
Similar funds
Mondrian Investment Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Mondrian Investment Partners held 111 positions worth $4.05B, up 40% from $2.89B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Mondrian Investment Partners deployed $461M of net new capital in Q4 2020, opening 6 new positions and adding to 40 existing holdings. Its largest new stake was American Tower: 69,083 shares worth $15.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Infosys, an estimated $35.4M trimmed.
- Mondrian Investment Partners's largest Q4 2020 buy was American Tower: 69,083 shares worth $15.5M.
- Mondrian Investment Partners added most to HCA Healthcare in Q4 2020, an estimated $55.6M increase.
- Mondrian Investment Partners's biggest Q4 2020 reduction was Infosys, cutting an estimated $35.4M.
- Mondrian Investment Partners fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $165K.
- Mondrian Investment Partners's ten largest holdings make up 46% of its $4.05B portfolio in Q4 2020.
- Mondrian Investment Partners opened 6 new positions and closed 1 in Q4 2020.
- Mondrian Investment Partners's portfolio value rose 40% quarter-over-quarter to $4.05B.
Based on Mondrian Investment Partners's 13F filing for Q4 2020, filed 11 Feb 2021.